α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95

British Journal of Pharmacology
M I Gaspar-ElsasP Xavier-Elsas

Abstract

α-Galactosylceramide (α-GalCer), a pleiotropic immunomodulator with therapeutic potential in neoplastic, autoimmune and allergic diseases, activates invariant natural killer T-cells throughCD1-restricted receptors for α-GalCer on antigen-presenting cells, inducing cytokine secretion. However the haemopoietic effects of α-GalCer remain little explored. α-GalCer-induced modulation of eosinophil production in IL-5-stimulated bone marrow cultures was examined in wild-type (BALB/c, C57BL/6) mice and their mutants lacking CD1, inducible NOS (iNOS), CD95 and IFN-γ, along with the effects of lymphocytes; IFN-γ; caspase and iNOS inhibitors; non-steroidal anti-inflammatory drugs (NSAIDs) and LTD4 ; and dexamethasone. α-GalCer (10(-6) -10(-8) M) suppressed IL-5-stimulated eosinopoiesis by inducing apoptosis. α-GalCer pretreatment in vivo (100 μg·kg(-1) , i.v.) suppressed colony formation by GM-CSF-stimulated bone marrow progenitors in semi-solid cultures. α-GalCer and dexamethasone synergistically promoted eosinophil maturation. Suppression of eosinophil production by α-GalCer was prevented by aminoguanidine and was undetectable in bone marrow lacking iNOS, CD95, CD28; or CD1d. Separation on Percoll gradients and depletion of CD3+ cells m...Continue Reading

References

Oct 1, 1973·European Journal of Immunology·M H JuliusL A Herzenberg
Jun 1, 1982·Biochemical Pharmacology·W R Mathews, R C Murphy
Nov 7, 1995·Proceedings of the National Academy of Sciences of the United States of America·V E LaubachP A Sherman
Nov 5, 1997·American Journal of Respiratory Cell and Molecular Biology·M I Gaspar ElsasB B Vargaftig
Mar 6, 2002·British Journal of Pharmacology·Letícia LintomenP Xavier Elsas
Oct 7, 2004·European Journal of Pharmacology·Hartmut KleinertPetra M Schwarz
Dec 4, 2004·The Journal of Allergy and Clinical Immunology·Jae-Ouk KimChang-Yuil Kang
Apr 2, 2005·American Journal of Respiratory Cell and Molecular Biology·Hiroyuki MatsudaHirotoshi Nakamura
Apr 30, 2005·Trends in Pharmacological Sciences·Celia R Berkers, Huib Ovaa
Sep 24, 2005·European Journal of Immunology·Patricia HachemMaria C Leite-de-Moraes
Dec 7, 2005·The Journal of Experimental Medicine·Kang LiuRalph M Steinman
Jan 30, 2007·Allergology International : Official Journal of the Japanese Society of Allergology·Chiaki Iwamura, Toshinori Nakayama
May 8, 2007·The Journal of Allergy and Clinical Immunology·Helene F RosenbergPaul S Foster
Oct 2, 2007·Journal of Neuroimmunology·Takashi YamamuraSachiko Miyake
May 27, 2008·Current Opinion in Immunology·Jennifer L MatsudaLaurent Gapin
Feb 24, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hye Young KimDale T Umetsu
Jun 11, 2009·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M I Gaspar-ElsasP Xavier-Elsas
Dec 17, 2009·American Journal of Respiratory and Critical Care Medicine·Tulio QuetoMaria Ignez Gaspar-Elsas
Mar 27, 2010·The Journal of Allergy and Clinical Immunology·Dale T Umetsu, Rosemarie H Dekruyff
Jul 8, 2010·The Journal of Gene Medicine·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
Jul 17, 2010·The Journal of Physiology·UNKNOWN NC3Rs Reporting Guidelines Working Group
Jul 24, 2010·British Journal of Pharmacology·J C McGrathC L Wainwright
Jul 24, 2010·British Journal of Pharmacology·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
Jan 27, 2011·European Journal of Immunology·Elvire A BourgeoisAndré Herbelin
Mar 9, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ya-Hui ChuangBor-Luen Chiang
Feb 22, 2012·Trends in Immunology·Gennaro De Libero, Lucia Mori
Apr 3, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Li-Ping LiShigeru Saito
Sep 24, 2013·JAK-STAT·Isabella RauchThomas Decker
Oct 15, 2013·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S JyonouchiA Cianferoni
Oct 31, 2013·BioMed Research International·P Xavier-ElsasM I Gaspar-Elsas
Nov 16, 2013·Nucleic Acids Research·Adam J PawsonUNKNOWN NC-IUPHAR
Feb 18, 2014·British Journal of Pharmacology·Stephen P H AlexanderUNKNOWN CGTP Collaborators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.